Rapid and sustained antidepressant effects of vaporized N,N-dimethyltryptamine: a phase 2a clinical trial in treatment-resistant depression

  • Roth G. Global burden of disease collaborative network. global burden of disease study 2017 (GBD 2017) results. Seattle, United States: Institute for health metrics and evaluation (IHME), 2018. Lancet. 2018;392:1736–88.

    Article 

  • Continue Reading